Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cabaletta Bio Inc.

    NASDAQ: CABA · Real-Time Price · USD
    1.93
    -0.01 (-0.26%)
    At close: Jun 17, 2025, 10:23 AM

    Cabaletta Bio Statistics

    Share Statistics

    Cabaletta Bio has 50.74M shares outstanding. The number of shares has increased by 1.24% in one year.

    Shares Outstanding

    n/a
    		 50.74M

    Shares Change (YoY)

    n/a
    		 1.24%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 78.6%

    Shares Floating

    n/a
    		 46.16M

    Failed to Deliver (FTD) Shares

    n/a
    		 12,042

    FTD / Avg. Volume

    n/a
    		 0.69%

    Short Selling Information

    The latest short interest is 6.2M, so 12.21% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 6.2M

    Short % of Shares Out

    n/a
    		 12.21%

    Short % of Float

    n/a
    		 12.61%

    Short Ratio (days to cover)

    n/a
    		 2.27

    Valuation Ratios

    The PE ratio is -0.97 and the forward PE ratio is -0.88. Cabaletta Bio's PEG ratio is -0.02.

    PE Ratio

    n/a
    		 -0.97

    Forward PE

    n/a
    		 -0.88

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 0.74

    P/FCF Ratio

    n/a
    		 -1.24

    PEG Ratio

    n/a
    		 -0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Cabaletta Bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6.15, with a Debt / Equity ratio of 0.1.

    Current Ratio

    n/a
    		 6.15

    Quick Ratio

    n/a
    		 6.15

    Debt / Equity

    n/a
    		 0.1

    Debt / EBITDA

    n/a
    		 -0.12

    Debt / FCF

    n/a
    		 -0.17

    Interest Coverage

    n/a
    		 167.3

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-719,652.17

    Employee Count

    n/a
    		 161

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -79.27% in the last 52 weeks. The beta is 2.79, so Cabaletta Bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.79

    52-Week Price Change

    n/a
    		 -79.27%

    50-Day Moving Average

    n/a
    		 1.55

    200-Day Moving Average

    n/a
    		 2.69

    Relative Strength Index (RSI)

    n/a
    		 52.02

    Average Volume (20 Days)

    n/a
    		 1,756,093

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -125.14M

    Net Income

    n/a
    		 -115.86M

    EBITDA

    n/a
    		 -125.14M

    EBIT

    n/a
    		 -116.61M

    Earnings Per Share (EPS)

    n/a
    		 -2.37
    Full Income Statement

    Balance Sheet

    The company has 163.96M in cash and 15.6M in debt, giving a net cash position of 148.36M.

    Cash & Cash Equivalents

    n/a
    		 163.96M

    Total Debt

    n/a
    		 15.6M

    Net Cash

    n/a
    		 148.36M

    Retained Earnings

    n/a
    		 -349.1M

    Total Assets

    n/a
    		 165.14M

    Working Capital

    n/a
    		 100.61M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -88.22M and capital expenditures -2.21M, giving a free cash flow of -90.43M.

    Operating Cash Flow

    n/a
    		 -88.22M

    Capital Expenditures

    n/a
    		 -2.21M

    Free Cash Flow

    n/a
    		 -90.43M

    FCF Per Share

    n/a
    		 -1.83
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    CABA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CABA is $22, which is 1034% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $22

    Price Target Difference

    n/a
    		 1034%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 9
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -3.87

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist